![Stephen D. Gillies](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen D. Gillies
Director Ejecutivo en Provenance Biopharmaceuticals Corp. .
Cargos activos de Stephen D. Gillies
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Provenance Biopharmaceuticals Corp.
![]() Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Director Ejecutivo | 01/01/2008 | - |
Fundador | 01/01/2008 | - | |
Presidente | 01/01/2008 | - | |
Delos Advisors Ltd.
![]() Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Consultor / Asesor | - | - |
Historial de carrera de Stephen D. Gillies
Antiguos cargos conocidos de Stephen D. Gillies.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Damon Biotech, Inc. | Director Técnico/Científico/I+D | - | - |
Abbott Biotech, Inc. | Director Técnico/Científico/I+D | - | - |
APELLIS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 20/07/2011 | - |
Galenea Corp.
![]() Galenea Corp. Pharmaceuticals: MajorHealth Technology Galenea Corp. is an emerging biotechnology company which engaged in the discovery of novel therapies for central nervous system (CNC) and respiratory diseases. The firm is focusing initially on utilizing proprietary technologies to generate calcineurin-related treatments for schizophrenia. It also offers synaptic transmission drug discovery platform for alzheimer’s disease (AD), parkinson’s disease, huntington’s disease, epilepsy, bipolar depression, schizophrenia, autism spectrum disorders, and traumatic brain injury. The company was founded Jianzhu chen, Susumu Tonegawa, Maria Karayiorgou, and David J. Gerber in 2004 and is headquartered in Wakefield, MA. | Director/Miembro de la Junta | - | - |
MERCK KGAA | Corporate Officer/Principal | - | - |
Lexigen Pharmaceuticals Corp.
![]() Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Fundador | - | - |
Presidente | - | - | |
Potentia Pharmaceuticals, Inc.
![]() Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Director/Miembro de la Junta | - | - |
Formación de Stephen D. Gillies.
University of Massachusetts | Undergraduate Degree |
Rutgers State University of New Jersey | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Francia | 2 |
Alemania | 2 |
Operativa
Director/Board Member | 3 |
Founder | 2 |
President | 2 |
Sectorial
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
MERCK KGAA | Health Technology |
APELLIS PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 7 |
---|---|
Potentia Pharmaceuticals, Inc.
![]() Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Provenance Biopharmaceuticals Corp.
![]() Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Health Technology |
Lexigen Pharmaceuticals Corp.
![]() Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Commercial Services |
Galenea Corp.
![]() Galenea Corp. Pharmaceuticals: MajorHealth Technology Galenea Corp. is an emerging biotechnology company which engaged in the discovery of novel therapies for central nervous system (CNC) and respiratory diseases. The firm is focusing initially on utilizing proprietary technologies to generate calcineurin-related treatments for schizophrenia. It also offers synaptic transmission drug discovery platform for alzheimer’s disease (AD), parkinson’s disease, huntington’s disease, epilepsy, bipolar depression, schizophrenia, autism spectrum disorders, and traumatic brain injury. The company was founded Jianzhu chen, Susumu Tonegawa, Maria Karayiorgou, and David J. Gerber in 2004 and is headquartered in Wakefield, MA. | Health Technology |
Damon Biotech, Inc. | Health Technology |
Abbott Biotech, Inc. | |
Delos Advisors Ltd.
![]() Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Finance |
- Bolsa de valores
- Insiders
- Stephen D. Gillies
- Experiencia